COO Poetting Sierk sold 50,000 shares of BNTX at $110.56 for $5.5M on 2026-04-22
Poetting Sierk, Chief Operating Officer of BioNTech SE, executed a sale of 50,000 shares at $110.56, reducing his holdings from 449,387 to 399,387 shares. The transaction occurred when the stock was trading 12.4% below its 52-week high of $120.54, though up 21.6% over the prior 30 days. The sale represents an 11.1% reduction in his shareholding, leaving him with a substantial remaining position of 399,387 shares. Without additional context on scheduled trading plans or specific motivations, the transaction itself is a routine portfolio adjustment from a senior executive at a $26.7B market-cap biotech firm.